Trial intelligence / Profile preview

Clonidine for Aggression and Sleep in Children With Tourette's and ADHD

NCT00152750Phase 4Unknown

Sponsor
University Health Network
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in sleep disorder comparing Clonidine with Placebo (2 arms). Primary endpoint: Differences between baseline and final polysomnographic sleep architecture measurements at 8 weeks. Status: unknown.

02

Drugs

clonidine
03

Conditions

sleep disorder

Beyond the preview

Go deeper on NCT00152750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00152750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call